High-content screening of small molecule inhibitors from nature that target prostate cancer metabolism

This project proposes to screen and evaluate a library of 472 novel compounds that were isolated from Australian plants, fungi and marine organisms. Compounds that inhibit metabolic pathways critical for prostate cancer growth and survival will be chosen. This project will identify new inhibitors from nature, providing knowledge for future large-scale screens and helping develop new anticancer agents.



Rohan Davis Griffith Institute for Drug Discovery & APCRC-Q
Colleen Nelson APCRC-Q, IHBI, QUT, TRI
Martin Sadowski APCRC-Q, IHBI, QUT, TRI

Administering Institution

Griffith University


2017 - 2018



PCFA $98 500

Upcoming Events

Mar 07, 2020 - Mar 10, 2020 USANZ 2020 Annual Scientific Meeting
International Convention Centre, Sydney, New South Wales
Mar 20, 2020 - Mar 24, 2020 EAU Congress 2020
RAI Amsterdam, The Netherlands
Mar 25, 2020 - Mar 29, 2020 World Science Festival Brisbane
Mar 28, 2020 - Mar 31, 2020 ENDO 2020
Moscone Center, San Francisco, USA
Apr 24, 2020 - Apr 29, 2020 AACR Annual Meeting 2020
San Diego Convention Center, San Diego, USA